Back to all studies
RecruitingNCT06369714

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.

This recruiting study focuses on adhd and currently lists sites or participation links in China.

ADHDOtherFrom 6 Years to 12 Years
In plain English

Key information made simple

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning. For people living with ADHD, access and fit can matter just as much as the treatment itself. If the findings are useful, they could expand practical options that fit more easily into real life. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests a mix of remote and in-person participation through a hospital, with sites including Changzheng Hospital, Naval Medical University in Shanghai and Changhai Hospital, Naval Medical University in Shanghai. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis and meeting the main study requirements, while common reasons not to take part include major medical issues that could make participation unsuitable and active substance or alcohol problems that could affect the results. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT06369714. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Mixes in-person and remote participation.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com